Robert Redd
Harvard University
H-index: 32
North America-United States
Top articles of Robert Redd
Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma
HemaSphere
2024/4
Genomic distinctions of HIV-and EBV-associated DLBCL in a diverse African cohort
Cancer Research
2024/3/22
Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial
JMIR Research Protocols
2024/3/11
Cristina Panaroni
H-Index: 12
Robert Redd
H-Index: 21
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP
Leukemia & Lymphoma
2024/2/21
Robert Redd
H-Index: 21
Donna Neuberg
H-Index: 84
CTLA-4 Blockade Leads to Enrichment of Active CD56dimCD16+ NK Cells and Depletion of Regulatory T Cells Following Infusion of Haploidentical Donor Memory-like Natural Killer …
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
2024/2/1
Ivabradine in the management of elevated resting heart rate associated with mediastinal radiation therapy
Heart Rhythm
2024/2/1
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib …
medRxiv
2024
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Annals of Hematology
2024/1
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population
Blood Advances
2024/4/9
Robert Redd
H-Index: 21
Lorelei Mucci
H-Index: 57
P-099 Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in high-risk smoldering multiple myeloma
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Robert Redd
H-Index: 21
Elizabeth Murphy
H-Index: 19
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Nature Medicine
2023/1/9
Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and …
Blood
2023/11/28
P-036 Real world single center expeirence of long-term toxicities with anti-BCMA CAR T-cell therapy in relapsed and refractory multiple myeloma
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Robert Redd
H-Index: 21
Irene Ghobrial
H-Index: 59
Paul Richardson
H-Index: 12
Kenneth Anderson
H-Index: 44
Baseline Immune State and T Cell Clonal Kinetics Are Associated with Response to CAR-T Therapy in Large B-Cell Lymphoma
Blood
2023/11/28
TCL-423 The Outcomes of Patients With T-Cell Prolymphocytic Leukemia After Allogenic Stem Cell Transplant: A Multicenter Retrospective Study
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
A Phase 2 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Cytarabine (Len plus MEC) in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Blood
2023/11/28
Detection of Maternal Malignancy after Abnormal Noninvasive Prenatal Testing (NIPT)
Blood
2023/11/28
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models
Blood Advances
2023/8/22
A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Blood
2023/11/28
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Blood
2023/8/17
